These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3607275)

  • 1. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation.
    Bauer KA; Rosenberg RD
    Blood; 1987 Aug; 70(2):343-50. PubMed ID: 3607275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S; Chen J; Diamond SL
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation.
    Bauer KA; Rosenberg RD
    Am J Med; 1989 Sep; 87(3B):39S-43S. PubMed ID: 2679069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
    Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
    Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.
    Bauer KA; Weiss LM; Sparrow D; Vokonas PS; Rosenberg RD
    J Clin Invest; 1987 Dec; 80(6):1527-34. PubMed ID: 2824564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hypercoagulable states by measurement of activation fragments and peptides.
    Boisclair MD; Ireland H; Lane DA
    Blood Rev; 1990 Mar; 4(1):25-40. PubMed ID: 2182146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interpretation of hemostatic and fibrinolytic markers].
    Asakura H
    Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S.
    Rosenberg RD; Bauer KA
    Hum Pathol; 1987 Mar; 18(3):253-62. PubMed ID: 2950042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.
    Zilberman-Rudenko J; Deguchi H; Shukla M; Oyama Y; Orje JN; Guo Z; Wyseure T; Mosnier LO; McCarty OJT; Ruggeri ZM; Eckle T; Griffin JH
    Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):901-913. PubMed ID: 32102568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.
    Bauer KA; Broekmans AW; Bertina RM; Conard J; Horellou MH; Samama MM; Rosenberg RD
    Blood; 1988 May; 71(5):1418-26. PubMed ID: 2965928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.
    Conway EM; Bauer KA; Barzegar S; Rosenberg RD
    J Clin Invest; 1987 Dec; 80(6):1535-44. PubMed ID: 3680513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
    Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.
    Dati F; Pelzer H; Wagner C
    Semin Thromb Hemost; 1998; 24(5):443-8. PubMed ID: 9834011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.